• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种列线图和风险分类系统预测初诊骨脊柱和骨盆肿瘤患者的癌症特异性生存。

A Nomogram and a Risk Classification System Predicting the Cancer-Specific Survival of Patients With Initially-Diagnosed Osseous Spinal and Pelvic Tumors.

机构信息

Department of Orthopedic Surgery, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou, Zhejiang, China.

Department of Orthopedic Surgery, Ningbo Yinzhou Second Hospital, Ningbo Zhejiang, China.

出版信息

Spine (Phila Pa 1976). 2020 Jun 15;45(12):E713-E720. doi: 10.1097/BRS.0000000000003404.

DOI:10.1097/BRS.0000000000003404
PMID:32039945
Abstract

STUDY DESIGN

Retrospective analysis.

OBJECTIVE

Our goal was to provide a predictive model and a risk classification system that predicts cancer-specific survival (CSS) from spinal and pelvic tumors.

SUMMARY OF BACKGROUND DATA

Primary bone tumors of the spinal and pelvic are rare, thus limiting the understanding of the manifestations and survival from these tumors. Nomograms are the graphical representation of mathematical relationships or laws that accurately predict individual survival.

METHODS

A total of 1033 patients with spinal and pelvic bone tumors between 2004 and 2016 were selected from the Surveillance, Epidemiology, and End Results (SEER) database. Multivariate Cox analysis was used on the training set to select significant predictors to build a nomogram that predicted 3- and 5-year CSS. We validate the precision of the nomogram by discrimination and calibration, and the clinical value of nomogram was assessed by making use of a decision curve analyses (DCA).

RESULTS

Data from 1033 patients with initially-diagnosed spinal and pelvic tumors were extracted from the SEER database. Multivariate analysis of the training cohort, predictors included in the nomogram were age, pathological type, tumor stage, and surgery. The value of C-index was 0.711 and 0.743 for the internal and external validation sets, respectively, indicating good agreement with actual CSS. The internal and external calibration curves revealed good correlation of CSS between the actual observation and the nomogram. Then, the DCA showed greater net benefits than that of treat-all or treat-none at all time points. A novel risk grouping system was established for CSS that can readily divide all patients into three distinct risk groups.

CONCLUSION

The proposed nomogram obtained more precision prognostic prediction for patients with initially-diagnosed primary spinal and pelvic tumors.

LEVEL OF EVIDENCE

摘要

研究设计

回顾性分析。

目的

我们的目标是提供一个预测模型和风险分类系统,用于预测脊柱和骨盆肿瘤的癌症特异性生存(CSS)。

背景数据摘要

脊柱和骨盆的原发性骨肿瘤很少见,因此限制了对这些肿瘤的表现和生存的了解。列线图是数学关系或定律的图形表示,可以准确预测个体生存。

方法

从监测、流行病学和最终结果(SEER)数据库中选择了 2004 年至 2016 年期间的 1033 名脊柱和骨盆骨肿瘤患者。使用多变量 Cox 分析对训练集进行分析,以选择显著预测因子来构建预测 3 年和 5 年 CSS 的列线图。我们通过区分度和校准来验证列线图的精度,并通过决策曲线分析(DCA)评估列线图的临床价值。

结果

从 SEER 数据库中提取了 1033 名最初诊断为脊柱和骨盆肿瘤的患者数据。对训练队列的多变量分析表明,列线图中包含的预测因子包括年龄、病理类型、肿瘤分期和手术。内部和外部验证集的 C 指数值分别为 0.711 和 0.743,表明与实际 CSS 具有良好的一致性。内部和外部校准曲线显示 CSS 与实际观察结果之间存在良好的相关性。然后,DCA 表明在所有时间点,净收益均大于治疗全部或治疗全部。建立了一个新的 CSS 风险分组系统,可以方便地将所有患者分为三个不同的风险组。

结论

所提出的列线图为最初诊断为原发性脊柱和骨盆肿瘤的患者提供了更精确的预后预测。

证据水平

3 级。

相似文献

1
A Nomogram and a Risk Classification System Predicting the Cancer-Specific Survival of Patients With Initially-Diagnosed Osseous Spinal and Pelvic Tumors.一种列线图和风险分类系统预测初诊骨脊柱和骨盆肿瘤患者的癌症特异性生存。
Spine (Phila Pa 1976). 2020 Jun 15;45(12):E713-E720. doi: 10.1097/BRS.0000000000003404.
2
Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.列线图预测Ⅰ期老年小细胞肺癌患者生存的建立与验证。
Bosn J Basic Med Sci. 2021 Oct 1;21(5):632-641. doi: 10.17305/bjbms.2020.5420.
3
Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.列线图预测 IIIC1 期宫颈癌患者的总生存和癌症特异性生存。
BMC Cancer. 2021 Apr 23;21(1):450. doi: 10.1186/s12885-021-08209-5.
4
Prediction of Minor Salivary Gland Carcinoma: A Novel Nomogram and Risk Classification System for Overall Survival and Cancer-Specific Survival.预测小唾液腺癌:一种用于总生存和癌症特异性生存的新的列线图和风险分类系统。
Otolaryngol Head Neck Surg. 2021 Feb;164(2):359-368. doi: 10.1177/0194599820938323. Epub 2020 Jul 21.
5
Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.开发和验证一个列线图模型以预测胃贲门癌患者的预后。
Sci Rep. 2020 Aug 24;10(1):14143. doi: 10.1038/s41598-020-71146-z.
6
A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study.一种基于 SEER 的预测初诊转移性食管癌患者癌症特异性生存的新型列线图和风险分类系统。
Ann Surg Oncol. 2019 Feb;26(2):321-328. doi: 10.1245/s10434-018-6929-0. Epub 2018 Oct 24.
7
A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma.基于 SEER 的列线图能准确预测尤文肉瘤的预后。
Sci Rep. 2021 Nov 22;11(1):22723. doi: 10.1038/s41598-021-02134-0.
8
Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.肉瘤样肝细胞癌列线图预后评估模型的建立与验证。
Adv Ther. 2020 Jul;37(7):3185-3205. doi: 10.1007/s12325-020-01357-3. Epub 2020 May 20.
9
Nomograms and risk classification systems predicting overall and cancer-specific survival in primary malignant cardiac tumor.预测原发性恶性心脏肿瘤总生存和癌症特异性生存的列线图及风险分类系统。
J Card Surg. 2019 Dec;34(12):1540-1549. doi: 10.1111/jocs.14299. Epub 2019 Nov 5.
10
Nomogram predicting cancer-specific survival in elderly patients with stages I-III colon cancer.预测 I-III 期老年结肠癌患者癌症特异性生存的列线图。
Scand J Gastroenterol. 2020 Feb;55(2):202-208. doi: 10.1080/00365521.2020.1720280. Epub 2020 Feb 1.

引用本文的文献

1
Development and validation of a nomogram for predicting survival in patients with cardiogenic shock.用于预测心源性休克患者生存率的列线图的开发与验证
Front Cardiovasc Med. 2025 Apr 29;12:1538395. doi: 10.3389/fcvm.2025.1538395. eCollection 2025.
2
A nomogram proposal for early prediction of intensive care unit admission in patients with acute antipsychotic poisoning.急性抗精神病药物中毒患者重症监护病房入院早期预测的列线图方案
Toxicol Res (Camb). 2023 Sep 19;12(5):873-883. doi: 10.1093/toxres/tfad078. eCollection 2023 Oct.
3
Identification and validation of a nomogram predicting cancer-specific survival for elderly patients with adult fibrosarcoma: a multicenter retrospective study.
预测成人纤维肉瘤老年患者癌症特异性生存的列线图的识别与验证:一项多中心回顾性研究
Front Oncol. 2023 Jul 12;13:1187942. doi: 10.3389/fonc.2023.1187942. eCollection 2023.
4
A Simple-to-Use Nomogram for Predicting Postoperative Early Death Risk in Elderly Patients with Spinal Tumors: A Population-Based Study.一种用于预测老年脊柱肿瘤患者术后早期死亡风险的简易列线图:一项基于人群的研究
J Oncol. 2023 Mar 4;2023:2805786. doi: 10.1155/2023/2805786. eCollection 2023.
5
Clinical characteristics, prognostic factors, and predictive model for elderly primary spinal tumor patients who are difficult to tolerate surgery or refuse surgery.难以耐受手术或拒绝手术的老年原发性脊柱肿瘤患者的临床特征、预后因素及预测模型
Front Oncol. 2022 Nov 10;12:991599. doi: 10.3389/fonc.2022.991599. eCollection 2022.
6
Individualized assessment of risk and overall survival in patients newly diagnosed with primary osseous spinal neoplasms with synchronous distant metastasis.对初诊原发性骨脊柱肿瘤合并远处转移患者的风险和总体生存进行个体化评估。
Front Public Health. 2022 Aug 22;10:955427. doi: 10.3389/fpubh.2022.955427. eCollection 2022.
7
Construction, Validation, and Visualization of Two Web-Based Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Elderly Patients with Primary Osseous Spinal Neoplasms.用于预测原发性脊柱骨肿瘤老年患者总生存期和癌症特异性生存期的两个基于网络的列线图的构建、验证及可视化
J Oncol. 2022 Apr 4;2022:7987967. doi: 10.1155/2022/7987967. eCollection 2022.
8
A Nomogram-Based Risk Classification System Predicting the Overall Survival of Patients With Newly Diagnosed Stage IVB Cervix Uteri Carcinoma.一种基于列线图的风险分类系统预测新诊断的IVB期子宫颈癌患者的总生存期。
Front Med (Lausanne). 2021 Jul 15;8:693567. doi: 10.3389/fmed.2021.693567. eCollection 2021.